EP3192023A1 - Journalisation intelligente pour la gestion de problèmes associés à la santé - Google Patents

Journalisation intelligente pour la gestion de problèmes associés à la santé

Info

Publication number
EP3192023A1
EP3192023A1 EP15771327.2A EP15771327A EP3192023A1 EP 3192023 A1 EP3192023 A1 EP 3192023A1 EP 15771327 A EP15771327 A EP 15771327A EP 3192023 A1 EP3192023 A1 EP 3192023A1
Authority
EP
European Patent Office
Prior art keywords
measurement
healthcare application
measurements
memory device
health data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP15771327.2A
Other languages
German (de)
English (en)
Inventor
Jeffery S. Reynolds
Kuen Chang
Amy Schwartz
Aaron Ferber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascensia Diabetes Care Holdings AG
Original Assignee
Ascensia Diabetes Care Holdings AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascensia Diabetes Care Holdings AG filed Critical Ascensia Diabetes Care Holdings AG
Publication of EP3192023A1 publication Critical patent/EP3192023A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G06Q10/109—Time management, e.g. calendars, reminders, meetings or time accounting
    • G06Q10/1093—Calendar-based scheduling for persons or groups
    • G06Q10/1095—Meeting or appointment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication

Definitions

  • the present invention generally relates to management of health-related issues. More specifically, the present invention is directed to systems and methods that log health data for more effective management of health-related issues, including diabetes.
  • a PWD typically uses a measurement device (e.g., a blood glucose meter) that calculates the glucose concentration in a fluid sample from the PWD, where the fluid sample is collected on a test sensor that is received by the measurement device.
  • a measurement device e.g., a blood glucose meter
  • aspects of the present invention provide systems and methods for logging health data for more effective management of health-related issues (e.g., diabetes).
  • embodiments employ a healthcare application that collects data according to adherence burst prompting, measurement and logging prescription, retroactive logging, and/or data display with an electronic calendar.
  • a system for diabetes management includes a measurement device configured to take a measurement of a health characteristic and a processing device communicatively coupled to the measurement device.
  • the processing device receives the measurement from the measurement device.
  • the processing device includes at least one memory device, a processor, and a user interface.
  • the at least one memory device stores the one or more measurements and computer-readable instructions for a healthcare application.
  • the processor executes the healthcare application.
  • the health care application displays and receives, via the user interface, supplemental health data in association with the one or more measurements.
  • the healthcare application allows a user to input the supplemental data according to adherence burst prompting, measurement and logging prescription, retroactive logging, and/or data display with an electronic calendar.
  • the healthcare application may prompt the user to take the measurement and to input the supplemental data according to varying aspects of these features.
  • the at least one memory device may store a plurality of previous measurements and identifies one or more previous measurements for retroactive entry of additional supplemental health data, and the healthcare application prompts the user to enter the additional supplemental health data retroactively.
  • the at least one memory device may store a plurality of previous measurements and the healthcare application prompts the user to take the measurement and input the supplemental health data according to an analysis of the plurality of previous measurements.
  • the at least one memory device may store computer-readable instructions for a calendar application and corresponding calendar data in which the processor executes the calendar application and the healthcare application prompts the user to input the supplemental health data based on the calendar data.
  • an apparatus comprises a measurement device configured to take a measurement of a health characteristic.
  • the measurement device includes at least one memory device, a processor, and a user interface.
  • the at least one memory device stores the one or more measurements and computer-readable instructions for a healthcare application.
  • the processor executes the healthcare application and the healthcare application displays and receives, via the user interface, supplemental health data in association with the one or more measurements.
  • the at least one memory device stores a prescription or schedule and the healthcare application prompts the user to take the measurement and input the supplemental health data according to the prescription or schedule.
  • FIG. 1 illustrates an example system that helps persons with diabetes (PWDs) to log health data that can be used for more effective diabetes management according to aspects of the present invention.
  • PWDs persons with diabetes
  • FIG. 2 illustrates an embodiment of the example system of FIG. 1.
  • FIG. 3 illustrates an example method for adherence burst prompting is illustrated, according to aspects of the present invention.
  • FIG. 4 illustrates an example method employing a measurement and logging prescription, according to aspects of the present invention.
  • FIG. 5 illustrates an example method employing retroactive logging, according to aspects of the present invention.
  • FIGS. 6A-B illustrates example displays of blood glucose data with an electronic calendar, according to aspects of the present invention.
  • Management of a health-related issue may involve analyzing recorded blood glucose data to develop a treatment plan.
  • a treatment plan for a PWD may include regulating dietary carbohydrate intake, implementing an intake regimen of insulin or other medications.
  • systems and methods according to aspects of the present invention allow persons with diabetes to log health data for more effective diabetes management.
  • Health data may include measurements of blood glucose that PWDs take with blood glucose meters.
  • Health data may also include additional supplemental information that enhances an understanding of the recorded blood glucose data.
  • a PWD may log supplemental health data relating to his/her physical state, behavior, recent activities, and health-related events that may explain particular blood glucose data.
  • a PWD may log any information on recent insulin intake, carbohydrate intake, physical activity (e.g., exercise), and general health (e.g., sickness, fatigue, etc.) relating to a specific blood glucose measurement.
  • Each recorded blood glucose measurement can be associated with logged supplemental health data via, for example, a timestamp.
  • blood glucose data may be logged automatically or manually, while supplemental health data is logged manually by the PWD.
  • HCP health care provider
  • aspects of the present invention provide systems and methods for logging health data that provide sufficient information for developing an effective treatment plan, but minimize the amount of effort and inconvenience on the part of the PWD.
  • embodiments include one or more of the following features:
  • Embodiments may prompt a PWD to take blood glucose measurements and log supplemental health data more frequently during a predefined time period. For example, a PWD may increase logging of blood glucose data and/or supplemental health data for a time period (e.g., approximately two weeks) just prior to a visit with an HCP. By logging more detailed and frequent health data during this brief period of time, the PWD provides a set of health data that represents blood glucose data, physical state, behavior (lifestyle), activities, and health-related events that the PWD typically experiences during other times. The PWD, however, is not required to conduct a burdensome and inconvenient level of measurement and logging for months.
  • this feature provides the HCP with a detailed snapshot that allows the HCP to develop, review and/or revise a treatment plan for the PWD.
  • the health data collected according to adherence burst prompting can also be analyzed with health data that is logged during other times.
  • Embodiments may prompt a PWD to take blood glucose measurements and to log certain health data according to a specific testing/logging prescription determined by an HCP.
  • the testing/logging prescription identifies times and/or events when measurements and/or logging of certain supplemental health data provides greater information content for analysis by the HCP. For example, if a PWD is adopting a new insulin regimen, the PWD may be prompted to take measurements immediately before and after a meal and to log corresponding insulin and carbohydrate intake so that the HCP can evaluate the insulin regimen. As another example, if a PWD is having trouble with nocturnal hypoglycemia, the PWD may be prompted to log carbohydrate intake during evening meals and to take a measurement at bedtime.
  • testing/logging prescriptions may set forth other requirements for measurement and/or logging.
  • the testing/logging pattern is tailored to collect health data that is important for a particular PWD.
  • Embodiments may enhance convenience and efficiency by allowing a PWD to retroactively log health data.
  • the PWD is not required to provide health data (particularly supplemental health data) at the time the measurement is taken. Rather, the PWD can log the health data later at a more convenient time.
  • retroactive logging can be achieved when the PWD has more free time, e.g., while waiting at an airport gate to board a flight.
  • embodiments can actively identify certain blood glucose data that may require supplemental information to be logged to explain the blood glucose data further. As such, the PWD may be actively prompted to provide, for certain blood glucose data, supplemental health data that may provide especially useful information for analyzing the blood glucose data.
  • health data may be analyzed to identify events, anomalies, and other blood glucose data of interest and to prompt the user to retroactively log additional health data for the blood glucose data. For example, if a morning hypoglycemic event is identified in recorded blood glucose data, the PWD may be prompted to log additional health data relating to the event, e.g., information about the meal from the preceding evening, insulin doses, or exercise. In some cases, when prompted, the PWD may optionally and conveniently select from a predefined list of possible explanations for the identified blood glucose data.
  • Embodiments may allow a PWD to use information stored in his/her personal electronic calendar to assist in providing supplemental information. Many people routinely schedule and track their daily activities using electronic calendars, which are widely available on many electronic devices, e.g., smart devices. Therefore, to enhance the convenience of logging supplemental health, embodiments allow a PWD to view blood glucose data with information from his/her electronic calendar. Embodiments may graphically display the blood glucose data over the electronic calendar as an overlay. Alternatively, embodiments may display the blood glucose data side by side. Embodiments may also allow convenient marking of calendar entries (e.g., with text and/or symbols) to be identified easily and paired with corresponding blood glucose data (with the appropriate date and time stamp).
  • calendar entries e.g., with text and/or symbols
  • a PWD may mark blood glucose data with calendar entries relating to scheduled workouts, holiday meals, travel, and events that may cause stress (e.g., important work deadlines, etc.).
  • calendar entries relating to scheduled workouts, holiday meals, travel, and events that may cause stress (e.g., important work deadlines, etc.).
  • a calendar entry may be marked with a hashtag to associate the entry with a blood glucose measurement.
  • Present embodiments enable a PWD to efficiently log supplemental health data that increases the information content and value of corresponding blood glucose data.
  • Embodiments allow targeted logging of health data.
  • embodiments allow a PWD to provide more information with optimized logging (better information with minimum effort).
  • embodiments allow HCPs to guide testing and logging to collect the health data they need to develop treatment plans and recommend lifestyle changes. By making the collection of health data more efficient and convenient, PWDs are encouraged to provide health data resulting in more accurate analysis and effective treatment.
  • FIG. 1 illustrates an example system 10 for implementing the features described above.
  • the system 10 includes a measurement device 100 and an external processing device 200.
  • the measurement device 100 includes an analog front end 102, a measurement interface (e.g., an electrochemical or optical measurement) 103, a main microcontroller 104, a memory 105, a wireless microcontroller 106, and an antenna 107.
  • a measurement interface e.g., an electrochemical or optical measurement
  • the analog front end 102 is coupled to the measurement interface 103, which includes hardware to receive a fluid sample directly or indirectly.
  • the measurement device 100 measures the concentration of an analyte in the fluid sample.
  • the fluid sample may include, for example, a whole blood sample, a blood serum sample, a blood plasma sample, other body fluids like ISF (interstitial fluid), saliva, and urine, as well as non-body fluids.
  • Analytes that may be analyzed include glucose, lipid profiles (e.g., cholesterol, triglycerides, LDL and HDL), microalbumin, hemoglobin Al c , fructose, lactate, or bilirubin.
  • aspects of the present invention may be employed to measure one or more characteristics of a sample, such as analyte concentration, enzyme and electrolyte activity, antibody titer, etc.
  • a sample such as analyte concentration, enzyme and electrolyte activity, antibody titer, etc.
  • the measurement interface 103 includes a port that receives a test sensor (not shown) configured to receive the fluid sample directly.
  • a test sensor (not shown) configured to receive the fluid sample directly.
  • a user may employ a lancing device to pierce a finger or other area of the body to produce a blood sample at the skin surface. The user may then collect this blood sample by placing the test sensor into contact with the sample.
  • the test sensor contains a reagent which reacts with the sample to indicate the concentration of an analyte in the sample.
  • the measurement interface 103 allows the reaction to be measured by the analog front end 102.
  • the test sensor may be an electrochemical test sensor.
  • An electrochemical test sensor typically includes a plurality of electrodes and a fluid-receiving area that receives the fluid sample and includes appropriate reagent(s) (e.g., enzyme(s)) for converting an analyte of interest (e.g., glucose) in a fluid sample (e.g., blood) into a chemical species that produces an electrical current which is electro chemically measurable by the components of the electrode pattern.
  • the measurement interface 103 allows the analog front end 102 to be coupled to the electrodes of the test sensor, and the analog front end 102 receives a raw signal from the respective measurement interface 103.
  • the test sensor may be an optical test sensor.
  • Optical test sensor systems may use techniques such as transmission spectroscopy, diffuse reflectance, or fluorescence spectroscopy for measuring the analyte concentration.
  • an indicator reagent system and an analyte in a sample of body fluid can be reacted to produce a chromatic reaction, as the reaction between the reagent and analyte causes the sample to change color.
  • the degree of color change is indicative of the analyte concentration in the body fluid.
  • the color change of the sample can be evaluated to measure the absorbance level of a transmitted light.
  • the measurement interface 103 allows a light to be transmitted to the test sensor and the analog front end 102 to receive a raw optical signal based on the light absorbed by, and reflected from, the fluid sample on the test sensor.
  • the analog front end 102 is employed to measure characteristic(s) of fluid samples received via the at least one measurement interface 103. It is understood that any number of measurement interfaces 103 (electrochemical, optical, etc.) may be coupled to the analog front end 102 to obtain any type of raw signal that can be translated into any type of measurement data. [0024] Also coupled to the analog front end 102, the main microcontroller 104 controls operative aspects of the measurement device 100 as described further below. For example, the main microcontroller 104 can manage the measurement sequence that determines how the actual electrochemical or optical measurement is performed and how the raw electrochemical or optical signal is obtained by the analog front end 102 from the respective measurement interface 103.
  • the main microcontroller 104 can determine how the raw signal received by the analog front end 102 is converted with a calculation sequence into a final measurement value (e.g., blood glucose concentration expressed as milligrams per deciliter (mg/dL)) that can be communicated to the user, e.g., by a display.
  • a final measurement value e.g., blood glucose concentration expressed as milligrams per deciliter (mg/dL)
  • the main microcontroller 104 in alternative embodiments may include a sufficient analog front end to measure characteristic(s) of a fluid sample received via the at least one measurement interface 103.
  • the main controller 104 shown in FIG. 1 may generally represent any number and configuration of processing hardware and associated components required to manage the operation of the measurement device 100.
  • the memory 105 may include any number of storage devices, e.g., EEPROM, flash memory, etc.
  • the memory 105 may store measurement data.
  • the memory 105 may store data, e.g., firmware, software, algorithm data, program parameters, patient entered (logged) data, calibration data, lookup tables, etc., that are employed in the operation of other components of the measurement device 200.
  • the measurement device 100 also includes an antenna 107 that allows the measurement device 100 to communicate wirelessly with the external processing device 200.
  • the external processing device 200 may be a smart device, such as a smart telephone, that includes a mobile application that can be paired with the measurement device 100 to provide the testing/logging features described above.
  • the external processing device 200 may be a tablet computer, a handheld or pocket personal computer, a personal digital assistant (PDA), a desktop or laptop personal computer (PC), or other similar processing/communication devices employing any operating system and communication functions.
  • the measurement device 100 may also include the wireless microcontroller 106 that controls communications through the antenna 107.
  • the main microcontroller 104 and the wireless microcontroller 106 are shown separately in FIG. 1, it is contemplated that a common microcontroller in alternative embodiments may be employed to control the wireless communications in addition to other aspects of the measurement device 100.
  • the external processing device 200 also includes an antenna 207 that allows the external processing device 200 to communicate wirelessly with the measurement device 100.
  • the measurement device 100 and the external processing device 200 may communicate via Bluetooth® wireless technology.
  • communication may be established by other wireless technologies, including near field communication (NFC), radio frequency (RF), personal area network (PAN), Wi-FiTM (IEEE 802.11), or the like.
  • NFC near field communication
  • RF radio frequency
  • PAN personal area network
  • Wi-FiTM IEEE 802.11
  • wired communication e.g., universal serial bus (USB).
  • the external processing device 200 includes a processor 204 that generally controls aspects of the external processing device 200.
  • the processor 204 provides the processing required to run software applications that reside on the external processing device 200.
  • a memory 205 on the external processing device 200 stores the computer-readable instructions for such software applications.
  • the memory 205 may include non- volatile memory, such as flash memory or the like, to store user software applications.
  • the memory 205 stores the computer-readable instructions for a healthcare application 12 that complements the operation of the measurement device 100.
  • the healthcare application 12 can provide the testing/logging features described above.
  • the external processing device 200 is a smart device, e.g., a smart telephone
  • the healthcare application 12 may be a mobile application that is downloaded onto the smart device by the user and executed by the processor 204.
  • the external processing device 200 provides a user interface to receive input from the user and a display 208, speakers, etc., to provide output to the user.
  • the external processing device 200 includes a touchscreen for receiving input and displaying output.
  • the healthcare application 12 may store and/or process measurements and/or other data communicated wirelessly from the measurement device 100. In some cases, the healthcare application 12 may statistically analyze the measurement data and provide advanced display of the statistical analysis on the display 208 of the external processing device 200. Indeed, the healthcare application 12 may provide features that are not available through the measurement device 100 alone, particularly because the external processing device 200 may have greater processing and display capabilities than the measurement device 100. [0030] In some embodiments, the healthcare application 12 is employed in a platform for delivering a variety of healthcare services relating to the use of the measurement device 100. For example, a company selling/distributing the measurement device 100 may provide its customers with the healthcare application 12 to provide features and services that enhance the measurement device 100.
  • the measurement device 100 can be communicatively coupled to the external processing device 200
  • aspects of the present invention can employ applications on the external processing device 200 to expand the use of the measurement device 100.
  • the measurement device 100 can be coupled to the external processing device 200 so that the healthcare application 12 residing on the external processing device 200 can be used to provide the testing/logging features.
  • the external processing device 200 includes a network interface 210 that allows the external processing device 200 to connect to an external network 20.
  • the network interface 210 may employ any technique to connect to the external network 20.
  • the network interface 210 may connect with the external network 20 wirelessly, e.g., Wi-FiTM (IEEE 802.11), cellular, etc., or via a wired technique, e.g., Ethernet, etc.
  • the external network 20 may be any type of network, e.g., wide-area network (WAN), local-area network (LAN), cloud, etc.
  • the external processing device 200 may access any resource available through the external network 20.
  • the external processing device 200 can access resources that relate to the operation of the measurement device 100.
  • the external processing device 200 communicates with an external server 30 over the external network 20, shown for example as a cloud network.
  • the external server 30 is related to some healthcare platform that delivers a variety of healthcare services relating to the use of the measurement device 100.
  • the external server 30 may act as the source of the healthcare application 12, which the external processing device 200 can receive over the external network 20 via the network interface 210.
  • the external servers residing with access to the network or cloud-based servers may actually run the healthcare application with the user interface established via the network on the external processing device 200.
  • the external processing device 200 can be communicatively coupled to resources on an external network 20
  • the external processing device 200 can generally receive, from any external sources, data that can be used in association with the measurement device 100. Furthermore, because the external processing device 200 can be communicatively coupled to the measurement device 100, the measurement device 100 can in turn receive such data from the external sources.
  • the healthcare application 12 may be employed to provide any combination of: (1) adherence burst prompting, (2) measurement and logging prescription, (3) retroactive logging, or (4) data display with electronic calendar.
  • the healthcare application 12, for example, may store the corresponding health data in the memory 205 of the external processing device 200, where it can be accessed and analyzed, e.g., by an HCP. Additionally or alternatively, the health data can be transmitted via the network interface 210 to an external server 30 of a healthcare platform, where it can also be accessed and analyzed.
  • the healthcare application 12 can prompt a PWD to take measurements and/or log supplemental health data according to adherence burst prompting.
  • Adherence burst prompting helps a PWD to take blood glucose measurements and log supplemental health data more frequently and with more detail during a predefined time period. This time period can be determined, for example, by an HCP, so that the PWD can provide sufficient health data to develop a treatment plan without requiring the PWD to take more measurements and log more health data than is necessary.
  • an HCP may only require detailed health data for a two-week time period just before the PWD's next appointment with the HCP.
  • the PWD is more likely to comply with the adherence burst prompting and provide the HCP with sufficient health data. It is contemplated that the time period may be shorter (e.g., 2-13 days or 4-10 days) or longer (e.g., 3 or 4 weeks).
  • the adherence burst prompting can be customized to accommodate specific aspects of the PWD and his/her lifestyle (i.e., a user profile) to enhance convenience and encourage compliance.
  • a user profile may be collected and stored by the healthcare application 12 on the external processing device 200 and/or an external server 30.
  • the user profile may indicate days and times when the user cannot take blood glucose measurements (e.g., during work commutes on public transportation, work meetings, etc.).
  • an example method 300 employing adherence burst prompting is illustrated.
  • act 305 an adherence burst prompting schedule for a predefined time period is received.
  • the initial set-up of the act 305 (adherence burst prompting) or ongoing HCP monitoring and in situ changes may be achieved by several methods.
  • a PWD or HCP may set this up using the healthcare application and user interface of the PWD mobile device in one embodiment.
  • the HCP may have his or her own application running on the same mobile device or a separate platform (e.g., mobile device, computer, cloud application) that pushes the adherence burst prompting schedule to the healthcare application 12.
  • this adherence burst set-up could be automatically initiated (likely after human authorization) by an interface between appointment scheduling software that can be part of an HCP's information system (e.g., practice management software, hospital information system, electronic health record system, or electronic medical record systems).
  • appointment scheduling software e.g., practice management software, hospital information system, electronic health record system, or electronic medical record systems.
  • the adherence burst prompting schedule may be stored by the healthcare application 12 on the memory 205.
  • an HCP may determine the adherence burst prompting schedule to collect sufficient and timely health data to develop a treatment plan for a PWD.
  • the PWD is prompted to take the more frequent measurements and/or log the more detailed health data over the predefined time period.
  • the prompts may be communicated, for example, by the healthcare application 12 via the external processing device 200, e.g., via the display 208.
  • the prompts may occur, for example, on an hourly basis, before or after meal times, or at any other appropriate times and/or intervals.
  • the health data (i.e., blood glucose data and any supplemental health data) is received in response to the prompts in step 310.
  • the health data is then stored for subsequent retrieval and analysis in act 320.
  • the PWD may input and store the health data via the healthcare application 12.
  • the healthcare application 12 can prompt a PWD to take blood glucose measurements and to log health data according to a specific testing/logging prescription determined by an HCP.
  • the term "prescription" includes guidance or instructions from an individual such as an HCP that influence the actions of the PWD or an application in relation to the PWD that uses available data.
  • the testing/logging prescription identifies times and/or events when measurements and/or certain logging by the PWD provides a more informative set of health data for analysis by the HCP. Like the adherence burst prompting, the PWD is prompted to provide health data that is particularly useful for the HCP in developing a treatment plan.
  • the testing/logging prescription can be defined so that the PWD is not required to take more measurements and log more health data than is necessary.
  • testing/logging prescription can be customized to accommodate specific aspects of the PWD and his/her lifestyle (i.e., a user profile) to enhance convenience and encourage compliance.
  • the initial set-up or ongoing HCP monitoring and in situ changes of the custom prescription logging scenario may be achieved by several methods.
  • a PWD or HCP may set this up using the healthcare application and user interface of the PWD processing device in one embodiment.
  • the HCP may have his or her own application running on the same processing device or a separate platform (e.g., mobile device, computer, cloud application) that pushes the prescription logging/testing protocol to the healthcare application 12.
  • this could be automatically initiated (likely after human authorization) through an interface with an HCP's information system (e.g., practice management software, hospital information system, electronic health record system, or electronic medical record systems).
  • an HCP's information system e.g., practice management software, hospital information system, electronic health record system, or electronic medical record systems.
  • the use of a standalone HCP application would also be coupled seamlessly with data analysis algorithms to look at the data collected from the prescription testing as well as make logging instructions in the patient electronic medical records more accurate and less manually intensive.
  • the HCP may be especially interested in monitoring the effects of meals and insulin intake on the glucose levels of the PWD. Accordingly, using measurement and logging prescription, the PWD is prompted to take measurements and log health data before and after meals. Additionally, the PWD is prompted with reminders to take insulin or other necessary medications on a schedule determined by the HCP. The health data logged according to the prescription allows the HCP to evaluate the insulin regimen.
  • a PWD may have a user profile that indicates that he/she normally eats lunch at noon and dinner at 7 PM. Based on this information, the HCP may, for instance, prescribe that the PWD should be prompted to take a blood glucose measurement and log supplemental data at 11 :45 AM, 1 PM, 6:45 PM, and 7: 15 PM. Of course, in other cases, the user profile may indicate that the user should be prompted at other appropriate times. In yet another example, if a PWD is having trouble with nocturnal hypoglycemia, the PWD may be prompted to log carbohydrate intake during evening meals and to take a blood glucose measurement at bedtime.
  • a testing/logging prescription is received from an HCP.
  • the prescription for example, may be stored by the healthcare application 12 on the memory 205.
  • an HCP defines the prescription to collect sufficient and timely health data, e.g., to develop or evaluate a treatment plan for a PWD.
  • the PWD is prompted to take blood glucose measurements and/or log health data as required by the prescription.
  • the prompts may be communicated, for example, by the healthcare application 12 via the external processing device 200, e.g., via the display 208.
  • the health data i.e., blood glucose data any supplemental health data
  • the health data is then stored for subsequent retrieval and analysis in act 420.
  • the PWD may input and store the health data via the healthcare application 12.
  • the healthcare application 12 allows a PWD to retroactively log health data.
  • the PWD is not required to provide health data (particularly supplemental health data) at the time the measurement is taken. Rather, the PWD can log the health data later at a more convenient time.
  • embodiments can actively identify certain blood glucose data that may require supplemental information be logged to explain the blood glucose data further.
  • the PWD may be actively prompted to provide, for certain blood glucose data, supplemental health data that may provide especially useful information for analyzing the blood glucose data.
  • health data may be analyzed to identify events, anomalies, and other blood glucose data of interest and to prompt the user to retroactively log additional health data for the blood glucose data.
  • the initial set-up or ongoing HCP monitoring and in situ changes of the retroactively logging scenario may be achieved by several methods.
  • a PWD or HCP may set this up using the healthcare application and user interface of the PWD processing device in one embodiment.
  • the HCP may have his or her own application running on the same processing device or a separate platform (e.g., mobile device, computer, cloud application) that pushes the retroactively logging protocol to the healthcare application 12.
  • this could be automatically initiated (likely after human authorization) through an interface with an HCP's information system (e.g., practice management software, hospital information system, electronic health record system, or electronic medical record systems).
  • an HCP's information system e.g., practice management software, hospital information system, electronic health record system, or electronic medical record systems.
  • the use of a standalone HCP application would also be coupled seamlessly with data analysis algorithms to look at the data collected from the retroactively logging to make the patient electronic medical records more accurate.
  • an example method 500 employing retroactive logging is illustrated.
  • stored health data e.g., blood glucose data
  • the health data may be stored in the memory 205 and the healthcare application 12 may analyze the health data to prompt the PWD for further information.
  • pattern recognition may be employed to identify events, anomalies, and other blood glucose data of interest. For example, if blood glucose data for a PWD falls consistently within a certain range every morning, a value that falls significantly outside this range may trigger a prompt to the PWD requesting supplemental information for the value.
  • the PWD is prompted to retroactively log supplemental health data for the measurements identified in act 505.
  • the prompts may be communicated, for example, by the healthcare application 12 via the external processing device 200, e.g., via the display 208.
  • supplemental health data is received in response to the prompts in step 510.
  • the supplemental health data is then stored for subsequent retrieval and analysis in act 520.
  • the PWD may input and store the supplemental health data via the healthcare application 12.
  • act 505 may identify measurements taken during the evening that do not have corresponding supplemental health data.
  • This supplemental health data may help an HCP determine why the PWD is experiencing low blood glucose levels in the morning.
  • the supplemental health data may include, for example, information on the PWD's evening meals (e.g., carbohydrate intake), the PWD's bedtime, or any other information that may provide context for the blood glucose data of interest.
  • the healthcare application 12 allows a PWD to use information stored in his/her personal electronic calendar to assist in providing supplemental information.
  • the external processing device 200 is a smart device, e.g., smart phone
  • the healthcare application 12 may access a calendar application typically available on such devices.
  • a PWD to view blood glucose data with information from his/her electronic calendar. Allowing a PWD to view logged health data with his/her electronic calendar is particularly convenient, as this allows the PWD to use calendar programs with which he/she is likely to be already familiar.
  • embodiments may graphically display the blood glucose data over the electronic calendar as an overlay.
  • embodiments may display the blood glucose data side by side.
  • Embodiments may also allow convenient marking of calendar entries (e.g., with text and/or symbols) to be identified easily and paired with corresponding blood glucose data (with the appropriate date and time stamp). For example, a calendar entry may be marked with a hashtag to associate the entry with a blood glucose measurement.
  • a PWD can receive prompts to take a measurement and/or log health data via the calendar application. These reminders can be displayed using the normal calendar interface, allowing the user to receive reminders more conveniently.
  • the prompts may include, for example, adherence burst prompts, testing/logging prescription prompts, retroactive logging prompts, or any other relevant logging prompts.
  • a PWD can log data directly into the calendar application that then can be accessed by the healthcare application 12.
  • the system 10 is employed, where the measurement device 100 (e.g., blood glucose meter) may be wirelessly coupled (e.g., via Bluetooth®) to an external processing device 200 (e.g., smart device) where a healthcare application 12 (e.g., mobile application) resides and is used to log, store, and view health care data.
  • a healthcare application 12 e.g., mobile application
  • aspects of the present invention can be implemented with a healthcare application 12 running on the external processing device, it is understood that some aspects may alternatively or additionally implemented on a standalone measurement device (i.e., without being coupled to an external processing device).
  • a measurement device may include at least one memory device, a processor and a user interface.
  • the at least one memory device of the measurement device stores the one or more measurements and computer-readable instructions for a healthcare application.
  • the healthcare application stored in the memory of the measurement device may allow a user to input the supplemental data according to (1) adherence burst prompting, (2) measurement and logging prescription, (3) retroactive logging, and/or (4) data display with an electronic calendar.
  • the healthcare application may prompt the user to take the measurement and to input the supplemental data according to varying aspects of these features.
  • the functionality of the healthcare applications described above in the system embodiments may be used in an apparatus with only the measurement device.
  • aspects of the present invention can be applied to other chronic disease and long term treatment management applications.
  • a healthcare application may prompt the patient to carefully log medications, exercise, and other relevant information over a period of time before each visit so that the HCP can better analyze the performance of the medical devices and make necessary adjustments.
  • the healthcare application can be programmed so that the prompting is tailored to the particular patient and their clinical situation. There are times in life when people can be intensively adherent for limited periods.
  • HCP's can use the aspects of the present invention to leverage the ability to request patients to engage in an adherence burst activity, e.g.,:
  • aspects of the present invention may also allow tailoring based on an individual's therapy and adherence profile:

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Human Resources & Organizations (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • General Business, Economics & Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Strategic Management (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Optics & Photonics (AREA)
  • Data Mining & Analysis (AREA)
  • Theoretical Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Tourism & Hospitality (AREA)
  • Quality & Reliability (AREA)
  • Operations Research (AREA)
  • Marketing (AREA)
  • Economics (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Selon l'invention, un système de gestion de problèmes associés à la santé (par exemple, le diabète) comprend un dispositif de mesure permettant de mesurer une caractéristique de santé et un dispositif de traitement accouplé en communication au dispositif de mesure. Le dispositif de traitement reçoit la mesure du dispositif de mesure. Le dispositif de traitement comprend au moins un dispositif mémoire, un processeur, et une interface utilisateur. Ledit dispositif mémoire stocke la ou les mesures et des instructions lisibles par ordinateur pour une application de soins de santé. Le processeur exécute l'application de soins de santé. L'application de soins de santé affiche et reçoit, par l'intermédiaire de l'interface utilisateur, des données de santé supplémentaires associées à la ou les mesures. L'application de soins de santé permet à un utilisateur de saisir les données supplémentaires selon une invite pour améliorer l'adhésion, une prescription de mesure et de journalisation, une journalisation rétroactive et/ou un affichage de données avec un calendrier électronique. L'application de soins de santé peut inviter l'utilisateur à prendre une mesure et à saisir les données supplémentaires en fonction de ces caractéristiques.
EP15771327.2A 2014-09-10 2015-09-08 Journalisation intelligente pour la gestion de problèmes associés à la santé Ceased EP3192023A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462048646P 2014-09-10 2014-09-10
PCT/US2015/048981 WO2016040345A1 (fr) 2014-09-10 2015-09-08 Journalisation intelligente pour la gestion de problèmes associés à la santé

Publications (1)

Publication Number Publication Date
EP3192023A1 true EP3192023A1 (fr) 2017-07-19

Family

ID=54207727

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15771327.2A Ceased EP3192023A1 (fr) 2014-09-10 2015-09-08 Journalisation intelligente pour la gestion de problèmes associés à la santé

Country Status (7)

Country Link
US (1) US20170277852A1 (fr)
EP (1) EP3192023A1 (fr)
JP (2) JP2017533495A (fr)
CN (2) CN112472077A (fr)
CA (1) CA2961061A1 (fr)
TW (1) TWI685815B (fr)
WO (1) WO2016040345A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105933536A (zh) * 2016-06-15 2016-09-07 孔马波 一种基于手机app的健康服务系统
EP3822639A4 (fr) * 2018-07-11 2022-04-27 Provigate Inc. Procédé de gestion de soins de santé
US20220020481A1 (en) 2020-07-20 2022-01-20 Abbott Laboratories Digital pass verification systems and methods
CN116417131B (zh) * 2023-04-04 2024-01-09 中国福利会国际和平妇幼保健院 一种孕产妇居家数据采集与实时监测方法和系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080300919A1 (en) * 2007-05-30 2008-12-04 Steven Charlton Architecture for health monitoring systems
EP2006786A1 (fr) * 2007-06-18 2008-12-24 Roche Diagnostics GmbH Procédé et système de surveillance de glucose pour surveillance individuelle de réponse métabolique et pour générer une réponse nutritionnelle
US20100331645A1 (en) * 2009-06-25 2010-12-30 Roche Diagnostics Operations, Inc. Methods and systems for wireless communication between a blood glucose meter and a portable communication device

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2284168A1 (fr) * 1997-03-13 1998-09-17 First Opinion Corporation Systeme de gestion de maladies
US6602191B2 (en) * 1999-12-17 2003-08-05 Q-Tec Systems Llp Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
US20130158367A1 (en) * 2000-06-16 2013-06-20 Bodymedia, Inc. System for monitoring and managing body weight and other physiological conditions including iterative and personalized planning, intervention and reporting capability
JP2002175372A (ja) * 2000-12-07 2002-06-21 Horonet Kk 病気治療管理システム
US20080177149A1 (en) * 2006-06-16 2008-07-24 Stefan Weinert System and method for collecting patient information from which diabetes therapy may be determined
MX338871B (es) * 2007-12-10 2016-05-04 Bayer Healthcare Llc Interfaz para sistema de medicion y monitoreo de salud.
US7821874B2 (en) * 2007-12-27 2010-10-26 At&T Intellectual Property I, L.P. Systems, methods and computer products for multiple reminder and sub-events for calendar items
US20090177147A1 (en) * 2008-01-07 2009-07-09 Michael Blomquist Insulin pump with insulin therapy coaching
US8317699B2 (en) * 2008-02-29 2012-11-27 Roche Diagnostics Operations, Inc. Device and method for assessing blood glucose control
CN102548467A (zh) * 2008-07-18 2012-07-04 生命扫描有限公司 分析物测量和管理装置及相关方法
CA2747332C (fr) * 2008-12-23 2015-01-27 F. Hoffmann-La Roche Ag Procede de gestion et systeme pour la mise en oeuvre, l'execution, le recueil de donnees et l'analyse de donnees d'une procedure de recueil structuree qui fonctionne sur un disposi tif de recueil
CN101785702B (zh) * 2009-01-23 2013-11-06 理康互联科技(北京)有限公司 健康信息系统、方法及对应装置、设备及试剂载体
US20120088989A1 (en) * 2009-12-21 2012-04-12 Roche Diagnostic Operations, Inc. Management Method And System For Implementation, Execution, Data Collection, and Data Analysis of A Structured Collection Procedure Which Runs On A Collection Device
JP5562094B2 (ja) * 2010-03-30 2014-07-30 テルモ株式会社 血糖測定装置
JP2013016031A (ja) * 2011-07-04 2013-01-24 Nec Corp データ管理システム、データ管理方法およびプログラム
WO2013170216A1 (fr) * 2012-05-11 2013-11-14 Wellsense Inc. Système mobile de surveillance de substance à analyser
CN103685358A (zh) * 2012-09-06 2014-03-26 中兴通讯股份有限公司 社交网络的事件提醒跟踪方法及装置
TWM457936U (zh) * 2013-03-07 2013-07-21 Yen-Ju Huang 健康資料收集整合利用裝置及系統
US9980671B2 (en) * 2013-03-15 2018-05-29 Johnnie J. Refvik Systems and methods for management of medical condition
TWM464766U (zh) * 2013-04-08 2013-11-01 Yong Dong Technology Co Ltd 生理資訊系統
US20140324445A1 (en) * 2013-04-26 2014-10-30 Roche Diagnostics Operations, Inc. Diabetes management system medical device usage statistics
US20150347708A1 (en) * 2014-05-30 2015-12-03 Anthony Michael Albisser Blood Glucose Meter And Computer-Implemented Method For Improving Glucose Management Through Modeling Of Circadian Profiles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080300919A1 (en) * 2007-05-30 2008-12-04 Steven Charlton Architecture for health monitoring systems
EP2006786A1 (fr) * 2007-06-18 2008-12-24 Roche Diagnostics GmbH Procédé et système de surveillance de glucose pour surveillance individuelle de réponse métabolique et pour générer une réponse nutritionnelle
US20100331645A1 (en) * 2009-06-25 2010-12-30 Roche Diagnostics Operations, Inc. Methods and systems for wireless communication between a blood glucose meter and a portable communication device

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016040345A1 *

Also Published As

Publication number Publication date
JP2017533495A (ja) 2017-11-09
CN112472077A (zh) 2021-03-12
CA2961061A1 (fr) 2016-03-17
JP7127090B2 (ja) 2022-08-29
CN106999041A (zh) 2017-08-01
US20170277852A1 (en) 2017-09-28
TW201614573A (en) 2016-04-16
CN106999041B (zh) 2020-10-30
JP2020184379A (ja) 2020-11-12
WO2016040345A1 (fr) 2016-03-17
TWI685815B (zh) 2020-02-21

Similar Documents

Publication Publication Date Title
US12102454B2 (en) Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US20210090737A1 (en) Method of hypoglycemia risk determination
JP6461885B2 (ja) 糖尿病管理のための分析物試験方法及びデバイス
JP7127090B2 (ja) 健康関連の問題の管理のためのスマートロギング
DK2797495T3 (en) HANDLED DIABETES MANAGER WITH A USER INTERFACE TO VIEW A STATE OF AN EXTERNAL PHARMACEUTICAL DEVICE
EP2654564B1 (fr) Étalonnage d'un dispositif portatif de gestion du diabète recevant des données d'une sonde de glycémie continue
JP2022514646A (ja) 断続的監視
Weinstock et al. The role of blood glucose monitoring in diabetes management
AU2013369674A1 (en) Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
US20120165639A1 (en) Storage of calibration data at a continuous glucose monitor
WO2012156323A1 (fr) Recueillement de données dynamique
US9213802B2 (en) Updatability of structured blood glucose tests performed on handheld diabetes management devices
US20150134344A1 (en) Personal Health Data Gathering for Incentive and Insurance Rating Purposes
Hirsch et al. Professional flash continuous glucose monitoring with ambulatory glucose profile reporting to supplement A1C: rationale and practical implementation
US11793471B2 (en) Method and system for monitoring a diabetes treatment plan
Bailey et al. Accuracy and user performance evaluation of the Contour® Next Link 2.4 blood glucose monitoring system
Kothare et al. Harnessing the potential of emerging digital health and biological sampling technologies for clinical drug development: promise to reality
Xu et al. Diabetes technology meeting 2021
RU2686048C2 (ru) Способ и устройство для определения уровня глюкозы в физиологической жидкости пациента и компьютерный программный продукт
van Drongelen et al. Blood glucose meters: Performance of devices on the Dutch market
Silva et al. Analytical performance of publicly dispensed glucometers in primary health care in a southern Brazilian city

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170315

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: FERBER, AARON

Inventor name: REYNOLDS, JEFFERY S.

Inventor name: CHANG, KUEN

Inventor name: SCHWARTZ, AMY

RIN1 Information on inventor provided before grant (corrected)

Inventor name: REYNOLDS, JEFFERY S.

Inventor name: CHANG, KUEN

Inventor name: FERBER, AARON

Inventor name: SCHWARTZ, AMY

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20171221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20230116